Velocity Clinical Research, Sioux City — Sioux City, Iowa

Velocity Clinical Research, Sioux City is a clinical research site located in Sioux City, Iowa, United States 51106.

Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research, Sioux City has participated in 12 clinical trials with 5 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, RSV Infection.

Sponsors: BioNTech SE, Gilead Sciences, Biohaven Therapeutics Ltd..

Sponsor Feasibility Report

Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research, Sioux City?

Velocity Clinical Research, Sioux City has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research, Sioux City conducted?

Velocity Clinical Research, Sioux City has 12 clinical trials on record, with 5 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, RSV Infection.

Is Velocity Clinical Research, Sioux City accredited by Crixeo Health?

Yes — Velocity Clinical Research, Sioux City holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research, Sioux City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.